GLP-1 Receptor Agonist Orforglipron for Adults with Obesity

N Engl J Med. 2023 Dec 14;389(24):2303. doi: 10.1056/NEJMc2311840.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glucagon-Like Peptide-1 Receptor Agonists*
  • Humans
  • Obesity / complications
  • Obesity / drug therapy

Substances

  • Glucagon-Like Peptide-1 Receptor Agonists